Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02965651 · ClinicalTrials.gov registry record · NA

Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study

A NA study of Stress, Emotional, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT02965651: Completed NA study of Stress, Emotional, sponsored by Boston Medical Center.

NCT02965651 is a NA study of Stress, Emotional that has completed, run by Boston Medical Center. The registered enrollment target is 61 participants, below the 373-participant average among 7 other Stress, Emotional trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02965651, a NA study of Stress, Emotional, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled trial is to evaluate the feasibility of introducing an innovative eHealth technology, the Embodied Conversational Agent (ECA), to diverse women from an urban outpatient setting.

Conditions Studied

Interventions

  • BEHAVIORAL ECA System

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2015-01
Est. Completion 2016-01
Phase NA
Boston Medical Center

253 total trials

What the finished NCT02965651 record still lists

NCT02965651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 373-participant average among 7 other Stress, Emotional trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Stress, Emotional appearing as the primary indexed condition, and to 1 intervention - of which ECA System is the first listed.

NCT02965651 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02965651 about?

NCT02965651 is a clinical study titled "Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study". The purpose of this randomized controlled trial is to evaluate the feasibility of introducing an innovative eHealth technology, the Embodied Conversational Agent (ECA), to diverse women from an urban outpatient setting.

What is the current status of trial NCT02965651?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-01. Estimated completion is 2016-01.

What conditions does trial NCT02965651 study?

This clinical trial studies the following conditions: Stress, Emotional.

What interventions are being tested in trial NCT02965651?

The interventions under investigation include: ECA System (BEHAVIORAL).

Who is sponsoring clinical trial NCT02965651?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02965651 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Emotional

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02965651, the US trial registry maintained by the National Library of Medicine. NCT02965651 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.